The realm of Intuitive Surgical (NasdaqGS:ISRG) is witnessing a paradigm shift as its one-year price target escalates to a riveting 419.02 per share. This surge marks a remarkable 16.22% upswing from the preceding estimate of 360.55 dated back to January 16, 2024.
Scrutinizing the precision of these forecasts, we encounter a diverse array rooted in analysts’ projections. Recent estimates lay scattered between a modest 325.72 and a formidable 483.00 per share, averaging a noteworthy 7.50% uptick from the latest closing price of 389.77 per share.
Navigating Fund Sentiment Waters
Embark on a journey through the capitalist seas surrounding Intuitive Surgical, where a grand ensemble of 2786 funds or institutions sway with positions in this entity. This flotilla has expanded by 126 owners, marking a 4.74% increase in the last quarter. The average portfolio weight devoted to ISRG now stands at 0.53%, witnessing a 6.85% reduction. Institutions’ total holdings have ascended by a modest 0.27% over the past three months to reach 342,469K shares. 
With the put/call ratio swaying at 1.43, a sense of caution permeates the atmosphere.
Diving Deeper into Shareholder Actions
Behold the landscape where Price T Rowe Associates hoists 16,973K shares, claiming a 4.82% stake in the company. In a prior revelation, the firm paraded 16,701K shares, marking a delightful elevation of 1.61%, showcasing their faith in ISRG. Their portfolio allegiance to ISRG surged by a notable 7.56% in the past quarter.
Delve into the tale where VTSMX – Vanguard Total Stock Market Index Fund Investor Shares clinches 10,938K shares, embodying a 3.10% possession of the company. In antecedent filings, they unveiled ownership of 10,931K shares, breathing life into a meager 0.07% growth. Nevertheless, their commitment to ISRG witnessed a noticeable downturn of 11.21% over the last quarter.
Witness the narrative where VFINX – Vanguard 500 Index Fund Investor Shares secures 8,443K shares, grasping a 2.40% share of the company. Compared to earlier disclosures of 8,343K shares, a gentle 1.19% rise is observed. However, their allegiance to ISRG underwent a poignant decline of 11.43% in the past quarter.
Gaze into the account where Alliancebernstein holds 7,300K shares, manifesting a 2.07% ownership of the company. In their past declaration, the firm paraded 6,766K shares, marking a robust ascent of 7.31%, illustrating a steadfast 12.64% surge in their portfolio allegiance to ISRG over the last quarter.
Unveil the narrative where Capital World Investors claim 7,211K shares, embodying 2.05% ownership in the company. Their previous filing boasted ownership of 7,559K shares, portraying a notable decline of 4.83%. Nevertheless, their portfolio dedication to ISRG witnessed a mild retraction of 1.15% throughout the last quarter.
A Glimpse into Intuitive Surgical’s Essence
(This insight has been graciously provided by the company itself.)
Bask in the vitality of Intuitive, the trailblazer nestled in Sunnyvale, California, heralded as a global maven in the realm of minimally invasive care and hailed as the vanguard of robotic-assisted surgery. Glimpse into their creed, where they fervently believe that minimally invasive care serves as a conduit to an enhanced life experience. Through a confluence of wit and technological brilliance, they empower physicians to heal sans boundaries, expanding the horizons of medical possibilities.
Embark on a voyage through the treasure trove that is Fintel, a haven of investing research catering to individual investors, traders, financial advisors, and modest hedge funds.
Cast your gaze upon our extensive data repositories spanning the globe, encompassing fundamentals, analyst deliberations, ownership insights, fund sentiment, options trends, insider trades, options flux, curious options maneuvers, and an abundance more. Moreover, our proprietary stock selections are fortified by sophisticated, meticulously backtested quantitative models curated with the sole aim of enhancing profitability across the board.
Click here to Discover More
This chronicle was originally featured on Fintel.
The perspectives and musings articulated herein are imbued with the author’s sentiments and viewpoints, maneuvering independently of those belonging to Nasdaq, Inc.
